Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

J Natl Compr Canc Netw 2014 Sep;12(9):1326-38

During the past few years, several genetic aberrations that may contribute to increased risks for development of breast and/or ovarian cancers have been identified. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian focus specifically on the assessment of genetic mutations in BRCA1/BRCA2, TP53, and PTEN, and recommend approaches to genetic testing/counseling and management strategies in individuals with these mutations. This portion of the NCCN Guidelines includes recommendations regarding diagnostic criteria and management of patients with Cowden Syndrome/PTEN hamartoma tumor syndrome.

Download full-text PDF

Source
https://www.tri-kobe.org/nccn/guideline/gynecological/englis
Web Search
September 2014
50 Reads

Publication Analysis

Top Keywords

assessment breast
8
nccn guidelines
8
high-risk assessment
8
breast ovarian
8
genetic/familial high-risk
8
mutations portion
4
guidelines genetic/familial
4
individuals mutations
4
strategies individuals
4
identified nccn
4
portion nccn
4
includes recommendations
4
guidelines includes
4
ovarian focus
4
cancers identified
4
ovarian cancers
4
management strategies
4
genetic testing/counseling
4
tp53 pten
4
approaches genetic
4

Similar Publications